HomeCompaniesMacromoltek

Computational antibody design

Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.
Active Founders
Monica Berrondo
Monica Berrondo

Monica Berrondo, Founder/CEO

Monica Berrondo, Ph.D., is an entrepreneur, scientist, and software engineer. Her expertise lies in antibody structure-prediction and analysis, protein functional analysis, protein mutational analysis, and computational approaches to complex scientific problems.
Susana Kaufmann
Susana Kaufmann

Susana Kaufmann, Founder/CTO

Macromoltek
Founded:2010
Batch:Winter 2018
Team Size:14
Status:
Active
Location:Austin, TX